Curis, Inc. ( CRIS) - Key Metrics
CRIS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$4.02 | -$4.52 | -$4.52 |
| 2026Q1 | $0 | -$24.99 | -$9.30 | -$9.30 |
| 2025Q4 | $1.45 | $24.58 | -$8.09 | -$8.09 |
| 2025Q3 | $4.05 | -$9.86 | -$7.10 | -$7.10 |
| 2025Q2 | $4.35 | -$13.61 | -$12.68 | -$12.68 |
CRIS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.65 |
| 2026Q1 | 0% | -0.11 |
| 2025Q4 | 0% | 0.20 |
| 2025Q3 | 0% | -0.85 |
| 2025Q2 | 0% | -0.85 |
CRIS
Price: $1.63
52 week price:
Earnings Per Share: -396.87 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 479800
Ebitda: -14.2 millionMarket Capitalization: 4.4 million